Literature DB >> 31316313

Challenges in Radiotherapy.

Stefanie Corradini1, David Krug2, Icro Meattini3,4, Gerd Fastner5, Christiane Matuschek6, Bruno Cutuli7.   

Abstract

Year:  2019        PMID： 31316313      PMCID： PMC6600036          DOI： 10.1159/000500847

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  49 in total

1.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

Authors:  Nina Bijker; Philip Meijnen; Johannes L Peterse; Jan Bogaerts; Irène Van Hoorebeeck; Jean-Pierre Julien; Massimiliano Gennaro; Philippe Rouanet; Antoine Avril; Ian S Fentiman; Harry Bartelink; Emiel J Th Rutgers
Journal:  J Clin Oncol       Date:  2006-06-26       Impact factor: 44.544

2.  Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.

Authors:  Jayant S Vaidya; David J Joseph; Jeffrey S Tobias; Max Bulsara; Frederik Wenz; Christobel Saunders; Michael Alvarado; Henrik L Flyger; Samuele Massarut; Wolfgang Eiermann; Mohammed Keshtgar; John Dewar; Uta Kraus-Tiefenbacher; Marc Sütterlin; Laura Esserman; Helle M R Holtveg; Mario Roncadin; Steffi Pigorsch; Marinos Metaxas; Mary Falzon; April Matthews; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2010-07-10       Impact factor: 79.321

3.  Long-term results of hypofractionated radiation therapy for breast cancer.

Authors:  Timothy J Whelan; Jean-Philippe Pignol; Mark N Levine; Jim A Julian; Robert MacKenzie; Sameer Parpia; Wendy Shelley; Laval Grimard; Julie Bowen; Himu Lukka; Francisco Perera; Anthony Fyles; Ken Schneider; Sunil Gulavita; Carolyn Freeman
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

4.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009).

Authors:  Csaba Polgár; Erik Van Limbergen; Richard Pötter; György Kovács; Alfredo Polo; Jaroslaw Lyczek; Guido Hildebrandt; Peter Niehoff; Jose Luis Guinot; Ferran Guedea; Bengt Johansson; Oliver J Ott; Tibor Major; Vratislav Strnad
Journal:  Radiother Oncol       Date:  2010-02-22       Impact factor: 6.280

5.  Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Authors:  Irene L Wapnir; James J Dignam; Bernard Fisher; Eleftherios P Mamounas; Stewart J Anderson; Thomas B Julian; Stephanie R Land; Richard G Margolese; Sandra M Swain; Joseph P Costantino; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2011-03-11       Impact factor: 13.506

6.  An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.

Authors:  Stephanie G MacAusland; Jaroslaw T Hepel; Frank K Chong; Shira L Galper; Jennifer S Gass; Robin Ruthazer; David E Wazer
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

Review 7.  259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Authors:  Salomone Di Saverio; Fausto Catena; Donatella Santini; Luca Ansaloni; Tommaso Fogacci; Stefano Mignani; Antonio Leone; Filippo Gazzotti; Stefano Gagliardi; Angelo De Cataldis; Mario Taffurelli
Journal:  Breast Cancer Res Treat       Date:  2007-08-09       Impact factor: 4.872

Review 8.  Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Authors:  C Correa; P McGale; C Taylor; Y Wang; M Clarke; C Davies; R Peto; N Bijker; L Solin; S Darby
Journal:  J Natl Cancer Inst Monogr       Date:  2010

9.  Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.

Authors:  Jack Cuzick; Ivana Sestak; Sarah E Pinder; Ian O Ellis; Sharon Forsyth; Nigel J Bundred; John F Forbes; Hugh Bishop; Ian S Fentiman; William D George
Journal:  Lancet Oncol       Date:  2010-12-07       Impact factor: 41.316

10.  Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.

Authors:  B Cutuli; C Lemanski; A Fourquet; B de Lafontan; S Giard; A Meunier; R Pioud-Martigny; F Campana; H Marsiglia; S Lancrenon; E Mery; F Penault-Llorca; E Fondrinier; C Tunon de Lara
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640
View more
  3 in total

1.  Adjuvant Radiotherapy for Breast Cancer: More than Meets the Eye.

Authors:  David Krug
Journal:  Breast Care (Basel)       Date:  2020-04-15       Impact factor: 2.860

Review 2.  Recent advances in radiotherapy of breast cancer.

Authors:  Jan Haussmann; Stefanie Corradini; Carolin Nestle-Kraemling; Edwin Bölke; Freddy Joel Djiepmo Njanang; Bálint Tamaskovics; Klaus Orth; Eugen Ruckhaeberle; Tanja Fehm; Svjetlana Mohrmann; Ioannis Simiantonakis; Wilfried Budach; Christiane Matuschek
Journal:  Radiat Oncol       Date:  2020-03-30       Impact factor: 3.481

3.  Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study.

Authors:  Antonella Ciabattoni; Fabiana Gregucci; Giuseppe D'Ermo; Alessandro Dolfi; Francesca Cucciarelli; Isabella Palumbo; Simona Borghesi; Alessandro Gava; Giovanna Maria Cesaro; Antonella Baldissera; Daniela Giammarino; Antonino Daidone; Francesca Maurizi; Marcello Mignogna; Lidia Mazzuoli; Vincenzo Ravo; Sara Falivene; Sara Pedretti; Edy Ippolito; Rosaria Barbarino; Daniela di Cristino; Alba Fiorentino; Cynthia Aristei; Sara Ramella; Rolando Maria D'Angelillo; Icro Meattini; Cinzia Iotti; Vittorio Donato; Silvia Chiara Formenti
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.